Nick Burgin
Nick Burgin is a representative from Eisai, the pharmaceutical company behind lecanemab, who expressed concerns about the NHS's readiness to tackle Alzheimer's disease and criticized the review process that led to the rejection of their drug, stating it would have been denied even if offered for free.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Nick Burgin, from Eisai said the NHS 'is not ready' for the challenge of tackling Alzheimer's.
5